Literature DB >> 19089924

Autoimmunity and lymphomagenesis.

Lynn R Goldin1, Ola Landgren.   

Abstract

For more than 50 years, links between autoimmunity and lymphomas have been described based on human and animal studies. Over the last 3 decades, many studies have addressed specific hypotheses about these associations using population level data. This has been accomplished by assessing previous autoimmune history in case-control studies of patients with lymphoma (mainly non-Hodgkin lymphoma) and myeloma, and by following cohorts of patients with various autoimmune diseases for subsequent development of lymphoma and multiple myeloma. In this article, we review our recently published series of association studies based on data from Scandinavia and from US Veterans and other relevant findings. We also discuss what these associations have revealed about the mechanisms and pathways underlying both autoimmunity and lymphoma. Finally, we discuss the future directions involving a combination of population and molecular studies that are needed to better define underlying biological mechanisms.

Entities:  

Mesh:

Year:  2009        PMID: 19089924      PMCID: PMC2666348          DOI: 10.1002/ijc.24141

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  54 in total

1.  Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia.

Authors:  Ola Landgren; Gloria Gridley; David Check; Neil E Caporaso; Linda Morris Brown
Journal:  Br J Haematol       Date:  2007-10-17       Impact factor: 6.998

2.  A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura.

Authors:  Sajjan Mittal; Morgan G Blaylock; Dominic J Culligan; Robert N Barker; Mark A Vickers
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

Review 3.  Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Authors:  Michael Voulgarelis; Fotini N Skopouli
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 4.  The use of TNF-alpha blocking agents in rheumatoid arthritis: an update.

Authors:  Eric Toussirot; Daniel Wendling
Journal:  Expert Opin Pharmacother       Date:  2007-09       Impact factor: 3.889

Review 5.  Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.

Authors:  Lynn R Goldin; Neil E Caporaso
Journal:  Br J Haematol       Date:  2007-12       Impact factor: 6.998

6.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

Review 7.  B-cell lymphoproliferation in chronic inflammatory rheumatic diseases.

Authors:  Arne Hansen; Peter E Lipsky; Thomas Dörner
Journal:  Nat Clin Pract Rheumatol       Date:  2007-10

8.  Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma.

Authors:  Lene Mellemkjaer; Ruth M Pfeiffer; Eric A Engels; Gloria Gridley; William Wheeler; Kari Hemminki; Jørgen H Olsen; Lene Dreyer; Martha S Linet; Lynn R Goldin; Ola Landgren
Journal:  Arthritis Rheum       Date:  2008-03

Review 9.  Recent advances in the genetics of RA susceptibility.

Authors:  J Bowes; A Barton
Journal:  Rheumatology (Oxford)       Date:  2008-02-07       Impact factor: 7.580

10.  Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.

Authors:  Karin Ekström Smedby; Claire M Vajdic; Michael Falster; Eric A Engels; Otoniel Martínez-Maza; Jennifer Turner; Henrik Hjalgrim; Paolo Vineis; Adele Seniori Costantini; Paige M Bracci; Elizabeth A Holly; Eleanor Willett; John J Spinelli; Carlo La Vecchia; Tongzhang Zheng; Nikolaus Becker; Silvia De Sanjosé; Brian C-H Chiu; Luigino Dal Maso; Pierluigi Cocco; Marc Maynadié; Lenka Foretova; Anthony Staines; Paul Brennan; Scott Davis; Richard Severson; James R Cerhan; Elizabeth C Breen; Brenda Birmann; Andrew E Grulich; Wendy Cozen
Journal:  Blood       Date:  2008-02-08       Impact factor: 22.113

View more
  31 in total

Review 1.  Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.

Authors:  Catarina Dias; David A Isenberg
Journal:  Nat Rev Rheumatol       Date:  2011-06       Impact factor: 20.543

2.  Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States.

Authors:  Jill Koshiol; Tram Kim Lam; Gloria Gridley; David Check; Linda Morris Brown; Ola Landgren
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

Review 3.  Molecular pathogenesis of Waldenstrom's macroglobulinemia.

Authors:  Esteban Braggio; Casey Philipsborn; Anne Novak; Lucy Hodge; Stephen Ansell; Rafael Fonseca
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

Review 4.  Genomics of lymphoid malignancies reveal major activation pathways in lymphocytes.

Authors:  Birgit Knoechel; Jens G Lohr
Journal:  J Autoimmun       Date:  2013-07-21       Impact factor: 7.094

5.  Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.

Authors:  Alexandra Nieters; Anna Łuczyńska; Susen Becker; Nikolaus Becker; Roel Vermeulen; Kim Overvad; Krasimira Aleksandrova; Heiner Boeing; Pagona Lagiou; Dimitrios Trichopoulos; Antonia Trichopoulou; Vittorio Krogh; Giovanna Masala; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Bas Bueno-de-Mesquita; Suzanne M Jeurnink; Elisabete Weiderpass; Eva Ardanaz; Maria-Dolores Chirlaque; María-José Sánchez; Soledad Sánchez; Signe Borgquist; Salma Butt; Beatrice Melin; Florentin Späth; Sabina Rinaldi; Paul Brennan; Rachel S Kelly; Elio Riboli; Paolo Vineis; Rudolf Kaaks
Journal:  Carcinogenesis       Date:  2014-09-30       Impact factor: 4.944

6.  Malignant lymphomas and autoimmunity-a single center experience from Hungary.

Authors:  László Váróczy; Edit Páyer; Zsuzsanna Kádár; Lajos Gergely; Zsófia Miltényi; Ferenc Magyari; Péter Szodoray; Arpád Illés
Journal:  Clin Rheumatol       Date:  2011-07-07       Impact factor: 2.980

7.  Acute inflammatory neuropathy with monoclonal anti-GM2 IgM antibodies, IgM-κ paraprotein and additional autoimmune processes in association with a diffuse large B-cell non-Hodgkin's lymphoma.

Authors:  Annette Milnik; Dirk Roggenbuck; Karsten Conrad; Claudius Bartels
Journal:  BMJ Case Rep       Date:  2013-01-21

8.  Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up.

Authors:  Sigurdur Y Kristinsson; Gloria Gridley; Robert N Hoover; David Check; Ola Landgren
Journal:  Haematologica       Date:  2013-09-20       Impact factor: 9.941

9.  Associations of Autoimmunity, Immunodeficiency, Lymphomagenesis, and Gut Microbiota in Mice with Knockins for a Pathogenic Autoantibody.

Authors:  Shweta Jain; Jerrold M Ward; Dong-Mi Shin; Hongsheng Wang; Zohreh Naghashfar; Alexander L Kovalchuk; Herbert C Morse
Journal:  Am J Pathol       Date:  2017-07-17       Impact factor: 4.307

10.  Common genetic variants in candidate genes and risk of familial lymphoid malignancies.

Authors:  Xueying Sharon Liang; Neil Caporaso; Mary Lou McMaster; David Ng; Ola Landgren; Meredith Yeager; Stephen Chanock; Lynn R Goldin
Journal:  Br J Haematol       Date:  2009-07-01       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.